Literature DB >> 27815842

Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Subrata Pramanik1, Yanuar Alan Sulistio1, Klaus Heese2.   

Abstract

Neurotrophins (NTs) are members of a neuronal growth factor protein family whose action is mediated by the tropomyosin receptor kinase (TRK) receptor family receptors and the p75 NT receptor (p75NTR), a member of the tumor necrosis factor (TNF) receptor family. Although NTs were first discovered in neurons, recent studies have suggested that NTs and their receptors are expressed in various types of stem cells mediating pivotal signaling events in stem cell biology. The concept of stem cell therapy has already attracted much attention as a potential strategy for the treatment of neurodegenerative diseases (NDs). Strikingly, NTs, proNTs, and their receptors are gaining interest as key regulators of stem cells differentiation, survival, self-renewal, plasticity, and migration. In this review, we elaborate the recent progress in understanding of NTs and their action on various stem cells. First, we provide current knowledge of NTs, proNTs, and their receptor isoforms and signaling pathways. Subsequently, we describe recent advances in the understanding of NT activities in various stem cells and their role in NDs, particularly Alzheimer's disease (AD) and Parkinson's disease (PD). Finally, we compile the implications of NTs and stem cells from a clinical perspective and discuss the challenges with regard to transplantation therapy for treatment of AD and PD.

Entities:  

Keywords:  Alzheimer’s disease; BDNF; NGF; Neurotrophin; Parkinson’s disease; Stem cell; TRK

Mesh:

Substances:

Year:  2016        PMID: 27815842     DOI: 10.1007/s12035-016-0214-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  736 in total

1.  Specific functions for ERK/MAPK signaling during PNS development.

Authors:  Jason M Newbern; Xiaoyan Li; Sarah E Shoemaker; Jiang Zhou; Jian Zhong; Yaohong Wu; Daniel Bonder; Steven Hollenback; Giovanni Coppola; Daniel H Geschwind; Gary E Landreth; William D Snider
Journal:  Neuron       Date:  2011-01-13       Impact factor: 17.173

2.  PAR-6-PAR-3 mediates Cdc42-induced Rac activation through the Rac GEFs STEF/Tiam1.

Authors:  Takashi Nishimura; Tomoya Yamaguchi; Katsuhiro Kato; Masato Yoshizawa; Yo-ichi Nabeshima; Shigeo Ohno; Mikio Hoshino; Kozo Kaibuchi
Journal:  Nat Cell Biol       Date:  2005-02-20       Impact factor: 28.824

Review 3.  Neurotrophin-4: the odd one out in the neurotrophin family.

Authors:  C F Ibáñez
Journal:  Neurochem Res       Date:  1996-07       Impact factor: 3.996

4.  TRAF6-mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor.

Authors:  Thangiah Geetha; Rajappa S Kenchappa; Marie W Wooten; Bruce D Carter
Journal:  EMBO J       Date:  2005-10-27       Impact factor: 11.598

5.  The biosynthesis and processing of proteins in the mouse 7S nerve growth factor complex.

Authors:  T L Darling; P E Petrides; P Beguin; P Frey; E M Shooter; M Selby; W J Rutter
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1983

6.  Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways.

Authors:  Fanie Barnabé-Heider; Freda D Miller
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

7.  Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

Authors:  L Olson; A Nordberg; H von Holst; L Bäckman; T Ebendal; I Alafuzoff; K Amberla; P Hartvig; A Herlitz; A Lilja
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1992

8.  Neurotrophin-3: a neurotrophic factor related to NGF and BDNF.

Authors:  P C Maisonpierre; L Belluscio; S Squinto; N Y Ip; M E Furth; R M Lindsay; G D Yancopoulos
Journal:  Science       Date:  1990-03-23       Impact factor: 47.728

Review 9.  The role of neurotrophins in axonal growth, guidance, and regeneration.

Authors:  Marios G Lykissas; Anna K Batistatou; Konstantinos A Charalabopoulos; Alexandros E Beris
Journal:  Curr Neurovasc Res       Date:  2007-05       Impact factor: 1.990

10.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

View more
  18 in total

1.  Interleukin-6-Mediated Induced Pluripotent Stem Cell (iPSC)-Derived Neural Differentiation.

Authors:  Yanuar Alan Sulistio; Han Kyu Lee; Sung Jun Jung; Klaus Heese
Journal:  Mol Neurobiol       Date:  2017-05-16       Impact factor: 5.590

2.  Modulation of Tropomyosin Receptor Kinase for the Treatment of Neurotrophin Diseases: Alzheimer's, Huntington's and Parkinson's.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2019-11-08       Impact factor: 4.345

Review 3.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

4.  Improvement of Cognitive Function in Ovariectomized Rats by Human Neural Stem Cells Overexpressing Choline Acetyltransferase via Secretion of NGF and BDNF.

Authors:  Eun-Jung Yoon; Yunseo Choi; Dongsun Park
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

5.  A Novel Divergent Gene Transcription Paradigm-the Decisive, Brain-Specific, Neural |-Srgap2-Fam72a-| Master Gene Paradigm.

Authors:  Nguyen Thi Thanh Ho; Arne Kutzner; Klaus Heese
Journal:  Mol Neurobiol       Date:  2019-01-26       Impact factor: 5.590

Review 6.  Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors.

Authors:  Jie Wang; Wei-Wei Hu; Zhi Jiang; Mei-Jiang Feng
Journal:  World J Stem Cells       Date:  2020-05-26       Impact factor: 5.326

Review 7.  Peptides Derived from Growth Factors to Treat Alzheimer's Disease.

Authors:  Suzanne Gascon; Jessica Jann; Chloé Langlois-Blais; Mélanie Plourde; Christine Lavoie; Nathalie Faucheux
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

Review 8.  Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington's Disease.

Authors:  Danielle A Simmons
Journal:  J Huntingtons Dis       Date:  2017

Review 9.  Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy.

Authors:  Tuane Bazanella Sampaio; Anne Suely Savall; Maria Eduarda Ziani Gutierrez; Simone Pinton
Journal:  Neural Regen Res       Date:  2017-04       Impact factor: 5.135

Review 10.  From Neural Crest Development to Cancer and Vice Versa: How p75NTR and (Pro)neurotrophins Could Act on Cell Migration and Invasion?

Authors:  Sabine Wislet; Geoffrey Vandervelden; Bernard Rogister
Journal:  Front Mol Neurosci       Date:  2018-08-23       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.